• Aucun résultat trouvé

NAME OF THE MEDICINAL PRODUCT [Invented name] 0.3 mg/mL + 5 mg/mL eye drops, solution bimatoprost/timolol 2

N/A
N/A
Protected

Academic year: 2022

Partager "NAME OF THE MEDICINAL PRODUCT [Invented name] 0.3 mg/mL + 5 mg/mL eye drops, solution bimatoprost/timolol 2"

Copied!
4
0
0

Texte intégral

(1)

1

LABELLING

(2)

2

PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON

1. NAME OF THE MEDICINAL PRODUCT

[Invented name] 0.3 mg/mL + 5 mg/mL eye drops, solution bimatoprost/timolol

2. STATEMENT OF ACTIVE SUBSTANCE(S)

One mL of solution contains 0.3 mg of bimatoprost and 5 mg of timolol (as 6.8 mg of timolol maleate).

3. LIST OF EXCIPIENTS

Excipients: Sodium chloride, disodium hydrogen phosphate heptahydrate, citric acid monohydrate, sodium hydroxide or/and hydrochloric acid (for pH adjustment) and water for injections.

4. PHARMACEUTICAL FORM AND CONTENTS Eye drops, solution.

1 x 3 mL 3 x 3 mL

5. METHOD AND ROUTE(S) OF ADMINISTRATION

Ocular use.

Read the package leaflet before use.

6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN

Keep out of the sight and reach of children.

7. OTHER SPECIAL WARNING(S), IF NECESSARY Remove contact lenses before use.

Does not contain any preservatives.

8. EXPIRY DATE EXP:

(3)

3

Discard 4 weeks after first opening.

Opened:

Opened (1):

Opened (2) Opened (3):

9. SPECIAL STORAGE CONDITIONS

10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE

11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER

<[To be completed nationally]>

12. MARKETING AUTHORISATION NUMBER(S)

<[To be completed nationally]>

13. BATCH NUMBER Lot:

14. GENERAL CLASSIFICATION FOR SUPPLY

<[To be completed nationally]>

15. INSTRUCTIONS ON USE

16. INFORMATION IN BRAILLE [Invented name] 0.3 mg/mL + 5 mg/mL

17. UNIQUE IDENTIFIER – 2D BARCODE

<2D barcode carrying the unique identifier included.>

18. UNIQUE IDENTIFIER – HUMAN READABLE DATA

PC: {number}

SN: {number}

NN: {number}

(4)

4

MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS BOTTLE

1. NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION

[Invented name] 0.3 mg/mL + 5 mg/mL eye drops, solution bimatoprost/timolol

Ocular use

2. METHOD OF ADMINISTRATION Read the package leaflet before use.

3. EXPIRY DATE

EXP:

Discard 4 weeks after first opening.

4. BATCH NUMBER Lot:

5. CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 3 mL

6. OTHER

Références

Documents relatifs

Tell your doctor before you have an operation that you are using [Invented name] as timolol may change effects of some medicines used during anaesthesia.. [Invented name] may

SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN.. Keep out of the sight and reach

Five clinical studies were conducted for DuoTrav 40 micrograms/mL + 5 mg/mL eye drops, solution (Alcon Laboratories) to support the efficacy and safety of the

[r]

Excipients: Macrogolglycerol hydroxystearate 40, sodium chloride, disodium edetate, sodium dihydrogen phosphate dihydrate, anhydrous disodium phosphate, hydrochloric acid or/and

The overall efficacy of the bimatoprost 0.03 %/timolol 0.5 % eye drops combination in the treatment of patients with open-angle glaucoma or ocular hypertension

[r]

Gerhard